chr14-34259025-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000551935.5(EGLN3):​n.60-89379C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.548 in 151,846 control chromosomes in the GnomAD database, including 23,058 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 23058 hom., cov: 30)

Consequence

EGLN3
ENST00000551935.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.393

Publications

2 publications found
Variant links:
Genes affected
EGLN3 (HGNC:14661): (egl-9 family hypoxia inducible factor 3) Enables peptidyl-proline 4-dioxygenase activity. Involved in several processes, including activation of cysteine-type endopeptidase activity involved in apoptotic process; peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia. Located in cytosol and nucleus. Implicated in renal cell carcinoma. Biomarker of clear cell renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.646 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000551935.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGLN3
ENST00000551935.5
TSL:4
n.60-89379C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.547
AC:
83043
AN:
151728
Hom.:
23020
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.621
Gnomad AMI
AF:
0.377
Gnomad AMR
AF:
0.604
Gnomad ASJ
AF:
0.497
Gnomad EAS
AF:
0.665
Gnomad SAS
AF:
0.545
Gnomad FIN
AF:
0.523
Gnomad MID
AF:
0.484
Gnomad NFE
AF:
0.489
Gnomad OTH
AF:
0.573
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.548
AC:
83137
AN:
151846
Hom.:
23058
Cov.:
30
AF XY:
0.549
AC XY:
40721
AN XY:
74182
show subpopulations
African (AFR)
AF:
0.621
AC:
25715
AN:
41398
American (AMR)
AF:
0.604
AC:
9233
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.497
AC:
1722
AN:
3466
East Asian (EAS)
AF:
0.664
AC:
3402
AN:
5122
South Asian (SAS)
AF:
0.545
AC:
2614
AN:
4794
European-Finnish (FIN)
AF:
0.523
AC:
5518
AN:
10548
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.489
AC:
33234
AN:
67936
Other (OTH)
AF:
0.577
AC:
1215
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1903
3806
5708
7611
9514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.525
Hom.:
11341
Bravo
AF:
0.554
Asia WGS
AF:
0.640
AC:
2230
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
9.2
DANN
Benign
0.74
PhyloP100
0.39

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11625217; hg19: chr14-34728231; API